Approval · Notice of Compliance 12204 · 2011
TACTUO: Notice of Compliance 12204
Issued March 21, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12204
- Date
- March 21, 2011
- Company
- Galderma Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Acne therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TACTUO | 02365871 | Marketed |
Medicinal ingredients
- ADAPALENE 0.1 PER
- BENZOYL PEROXIDE 2.5 PER